Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer

European Journal of Cancer

Volumn 35, Issue 13, 1999, Pages 1828-1837

  Voogd, A C ^a,b,c   Peterse, J L ^b   Crommelin, M A ^c   Rutgers, E J Th ^b   Botke, G ^d,e,f,g,h   Elkhuizen, P H M ⁱ   Van Geel, A N ^a   Hoekstra, C J M ⁱ   Van Pel, R ^a   Van De Vijver, M J ^c   Coebergh, J W W ^b  

^a The Netherlands   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d Radiotherapeutisch Instituut Friesland   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g Radiotherapeutic Institute Stedendriehoek en Omstreken   (Netherlands)

^h SINT FRANCISCUS GASTHUIS   (Netherlands)

ⁱ ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Breast cancer; Breast conservation; Cancer; Determinants; Local recurrence

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS;

EID: 0032718321     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00220-8     Document Type: Article

References (45)

1. Fisher B, Redmond G, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989, 320, 822-828.
2. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989, 14, 177-184.
3. Veronesi U, Banfi A, Del Vecchio M, et al. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol 1986, 9, 1085-1089.
4. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992, 11, 19-25.
5. van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer. J Natl Cancer Inst Monogr 1992, 11, 15-18.
6. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995, 333, 1444-1455.
7. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991, 338, 327-331.
8. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant métastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995, 87, 19-27.
9. Kemperman H, Borger J, Hart A, Peterse H, Bartelink H, van Dongen J. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer: the role of local recurrence. Eur J Cancer 1995, 31A, 690-698.
10. Galle R, Vilcoq JR, Zafrani B, Vielh P, Fourquet A. Local control and survival of breast cancer treated by limited surgery followed by irradiation. IntJ Radiât Oncol Biol Phys 1986,12, 873-878.
11. van Limbergen E, van der Bogaert W, van der Schueren E, Rijnders A. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patients and treatment parameters and local control. Radiother Oncol 1987, 8, 1-9.
12. Stotter AT, McNeese MD, Ames FC, Oswald MJ, Ellerbroek NA. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 1989, 64, 2217-2225.
13. Kurtz JM, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in young patients? J Clin Oncol 1990, 8, 591-598.
14. Haffty BG, Fischer D, Rose M, Beinfield M, McKhann C. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data. JClin Oncol 1991, 9, 997-1003.
15. Fowble BL, Schultz DJ, Overmoyer B, et al. The influence of young age on outcome in early stage breast cancer. Int J Radiât Oncol Biol Phys 1994, 30, 23-33.
16. van Dongen JA, Bartelink H, Fentiman IS, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992, 28A, 801-805.
17. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RR. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 1984, 53, 1049-1057.
18. Bartelink H, Borger JH, van Dongen JA, Peterse JL. The impact of tumor size and histology on local control after breast-conserving therapy. Radiother Oncol 1988, 11, 297-303.
19. Kurtz JM, Jacquemier J, Amalric R, et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990, 65, 1867-1878.
20. Lagios MD. Pathologic features related to local recurrence following lumpectomy and irradiation. Semin Surg Oncol 1992, 8, 122-128.
21. Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiât Oncol Biol Phys 1989, 17, 719-725.
22. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J. Risk factors in breast-conservation therapy. J Clin Oncol 1994, 12, 653-660.
23. Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994, 74, 1746-1751.
24. Dewar JA, Arriagada R, Benhamou S, et al. Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group. Cancer 1995, 76, 2260-2265.
25. Hermanek P, Sobin LH, ed. UICC TNM Classification of Malignant Tumors, 4th edn. Berlin, Springer, 1987, 94-99.
26. Baak JP, van Dop H, Kurver PH, Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer 1985, 56, 374-382.
27. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume I. The Analysis of Case-Control Studies. IARC Scientific Publications, No. 32. Lyon, International Agency for Research on Cancer, 1980.
28. van Leeuwen FE, Benraadt J, Coebergh JWW, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994, 343, 448-452.
29. Kurtz JM, Jacquemier J, Torhorst J, et al. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 1989, 63, 1630-1635.
30. Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 1989, 64, 448-454.
31. White JR, Gustafson GS, Wimbish K, et al. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. Cancer 1994, 74, 640-647.
32. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic pattern. Cancer 1996, 77, 113-120.
33. Warneke J, Berger R, Johnson C, Stea D, Villar H. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. Am J Surg 1996, 172, 496-500.
34. Salvador! B, Biganzoli E, Veronesi P, Saccozzi R, Rilke F. Conservative surgery for infiltrating lobular carcinoma. Br J Surg 1997,84, 106-109.
35. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990, 8, 113-118.
36. Vicini FA, Eberlein TJ, Connolly JL, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991, 214, 200-205.
37. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989, 63, 618-624.
38. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma in situ. Lancet 1995, 345, 1154-1157.
39. Fisher E, Anderson S, Redmond C, Fisher B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol 1992, 8, 161-166.
40. Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1990, 26A, 671-673.
41. Ghossein NA, Alpert S, Barba J, et al. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively. Arch Surg 1992, 127, 411-415.
42. Macmillan RD, Purushotham AD, Mallon E, Ramsay G, George WD. Breast-conserving surgery and tumour bed positivity in patients with breast cancer. BrJ Surg 1994, 81, 56-58.
43. Guidi AJ, Connolly JL, Harris JR, Schnitt SJ. The relationship between shaved margin and inked margin status in breast excision specimens. Cancer 1997, 79, 1568-1573.
44. Kurtz JM. Factors influencing the risk of local recurrence in the breast. Eur J Cancer 1992, 28A, 660-666.
45. Harris JR. What have we learned about risk factors for local recurrence after breast-conserving surgery and irradiation? J Clin Oncol 1884, 12, 647-649.